Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service.

Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, Hubbard RB.

Thorax. 2011 Dec;66(12):1078-84. doi: 10.1136/thx.2011.158972.

PMID:
21785158
2.

The impact of the 'hub and spoke' model of care for lung cancer and equitable access to surgery.

Khakwani A, Rich AL, Powell HA, Tata LJ, Stanley RA, Baldwin DR, Duffy JP, Hubbard RB.

Thorax. 2015 Feb;70(2):146-51. doi: 10.1136/thoraxjnl-2014-205841.

PMID:
25182047
3.

Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.

Wouters MW, Siesling S, Jansen-Landheer ML, Elferink MA, Belderbos J, Coebergh JW, Schramel FM.

Eur J Surg Oncol. 2010 Sep;36 Suppl 1:S83-92. doi: 10.1016/j.ejso.2010.06.020.

PMID:
20598845
4.

Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer.

Virgo KS, Little AG, Fedewa SA, Chen AY, Flanders WD, Ward EM.

J Am Coll Surg. 2011 Nov;213(5):633-43. doi: 10.1016/j.jamcollsurg.2011.07.014.

PMID:
21907598
5.

Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.

Birim O, Kappetein AP, Bogers AJ.

Eur J Cardiothorac Surg. 2005 Nov;28(5):759-62.

PMID:
16157485
6.

The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.

Lüchtenborg M, Jakobsen E, Krasnik M, Linklater KM, Mellemgaard A, Møller H.

Eur J Cancer. 2012 Dec;48(18):3386-95. doi: 10.1016/j.ejca.2012.06.012.

PMID:
22795582
7.

Survival of Australian lung cancer patients and the impact of distance from and attendance at a thoracic specialist centre: a data linkage study.

Tracey E, McCaughan B, Badgery-Parker T, Young J, Armstrong B.

Thorax. 2015 Feb;70(2):152-60. doi: 10.1136/thoraxjnl-2014-205554.

PMID:
25074705
8.

The influence of provider characteristics on resection rates and survival in patients with localized non-small cell lung cancer.

Li WW, Visser O, Ubbink DT, Klomp HM, Kloek JJ, de Mol BA.

Lung Cancer. 2008 Jun;60(3):441-51. doi: 10.1016/j.lungcan.2007.10.029.

PMID:
18164099
9.

The effect of race on invasive staging and surgery in non-small-cell lung cancer.

Lathan CS, Neville BA, Earle CC.

J Clin Oncol. 2006 Jan 20;24(3):413-8.

PMID:
16365180
10.

Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006.

Riaz SP, Lüchtenborg M, Jack RH, Coupland VH, Linklater KM, Peake MD, Møller H.

Eur J Cancer. 2012 Jan;48(1):54-60. doi: 10.1016/j.ejca.2011.07.012.

PMID:
21871792
11.

Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit.

Khakwani A, Rich AL, Powell HA, Tata LJ, Stanley RA, Baldwin DR, Duffy JP, Hubbard RB.

Br J Cancer. 2013 Oct 15;109(8):2058-65. doi: 10.1038/bjc.2013.572.

12.

Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).

Ma Q, Liu D, Guo Y, Shi B, Song Z, Tian Y.

Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):342-8. doi: 10.3779/j.issn.1009-3419.2010.04.14.

13.

Surgical resection for non-small cell lung cancer: clinical features and outcomes for a consecutive series at an Irish tertiary referral centre.

Al-Alao BS, O'Callaghan DS, Gately K, Nicholson S, Coate LE, O'Connell F, McGovern E, O'Byrne KJ, Young VK.

Ir J Med Sci. 2013 Jun;182(2):217-25. doi: 10.1007/s11845-012-0863-0.

PMID:
23139062
14.

Do women live longer following lung resection for carcinoma?

Alexiou C, Onyeaka CV, Beggs D, Akar R, Beggs L, Salama FD, Duffy JP, Morgan WE.

Eur J Cardiothorac Surg. 2002 Feb;21(2):319-25.

PMID:
11825743
15.

Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.

Firat S, Bousamra M, Gore E, Byhardt RW.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1047-57.

PMID:
11958901
16.

How do patient and hospital features influence outcomes in small-cell lung cancer in England?

Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, Hubbard RB.

Br J Cancer. 2011 Sep 6;105(6):746-52. doi: 10.1038/bjc.2011.310.

17.

Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer.

Battafarano RJ, Piccirillo JF, Meyers BF, Hsu HS, Guthrie TJ, Cooper JD, Patterson GA.

J Thorac Cardiovasc Surg. 2002 Feb;123(2):280-7.

18.

[Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].

Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.

Dtsch Med Wochenschr. 2006 Nov 24;131(47):2643-8. German.

PMID:
17109272
20.

Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.

Iezzoni LI, Ngo LH, Li D, Roetzheim RG, Drews RE, McCarthy EP.

Arch Phys Med Rehabil. 2008 Apr;89(4):595-601. doi: 10.1016/j.apmr.2007.09.042. Review.

PMID:
18373987
Items per page

Supplemental Content

Support Center